8,814 Shares in Dolby Laboratories $DLB Bought by Caxton Associates LLP

Key Points

• Caxton Associates LLP invested approximately $708,000 in Dolby Laboratories by acquiring 8,814 shares during the first quarter.
• Dolby Laboratories has received reaffirmed ratings from several analysts, with a consensus rating of "Moderate Buy" and an average target price of $95.75.
• The company recently announced a quarterly dividend of $0.33 per share, with a payout ratio of 48.35% and a dividend yield of 1.9%.

Caxton Associates LLP bought a new stake in Dolby Laboratories (NYSE:DLB - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 8,814 shares of the electronics maker's stock, valued at approximately $708,000.

A number of other hedge funds have also recently added to or reduced their stakes in DLB. Goldman Sachs Group Inc. raised its holdings in shares of Dolby Laboratories by 218.8% in the first quarter. Goldman Sachs Group Inc. now owns 249,574 shares of the electronics maker's stock valued at $20,043,000 after buying an additional 171,288 shares during the last quarter. Kestra Investment Management LLC acquired a new position in Dolby Laboratories in the 1st quarter valued at about $107,000. Jones Financial Companies Lllp raised its stake in Dolby Laboratories by 241,160.1% during the 1st quarter. Jones Financial Companies Lllp now owns 429,443 shares of the electronics maker's stock valued at $36,975,000 after acquiring an additional 429,265 shares during the last quarter. Sepio Capital LP lifted its position in Dolby Laboratories by 68.6% during the 1st quarter. Sepio Capital LP now owns 18,188 shares of the electronics maker's stock worth $1,461,000 after acquiring an additional 7,403 shares during the period. Finally, Jacobs Levy Equity Management Inc. grew its stake in shares of Dolby Laboratories by 359.8% in the 1st quarter. Jacobs Levy Equity Management Inc. now owns 43,923 shares of the electronics maker's stock valued at $3,527,000 after purchasing an additional 34,370 shares during the last quarter. Hedge funds and other institutional investors own 58.56% of the company's stock.

Dolby Laboratories Trading Down 0.9%

Shares of NYSE:DLB traded down $0.63 during midday trading on Friday, hitting $71.48. 337,864 shares of the stock were exchanged, compared to its average volume of 440,754. Dolby Laboratories has a twelve month low of $68.24 and a twelve month high of $89.66. The company has a 50 day moving average price of $73.73 and a 200-day moving average price of $75.49. The stock has a market cap of $6.85 billion, a P/E ratio of 26.18 and a beta of 0.93.

Dolby Laboratories (NYSE:DLB - Get Free Report) last announced its earnings results on Thursday, July 31st. The electronics maker reported $0.78 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.72 by $0.06. The company had revenue of $315.55 million during the quarter, compared to analysts' expectations of $305.23 million. Dolby Laboratories had a net margin of 19.62% and a return on equity of 11.52%. The firm's quarterly revenue was up 9.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.71 earnings per share. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. On average, equities research analysts expect that Dolby Laboratories will post 2.94 earnings per share for the current year.

Dolby Laboratories Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, August 20th. Investors of record on Tuesday, August 12th were paid a dividend of $0.33 per share. The ex-dividend date of this dividend was Tuesday, August 12th. This represents a $1.32 dividend on an annualized basis and a dividend yield of 1.8%. Dolby Laboratories's dividend payout ratio (DPR) is presently 48.35%.

Insider Transactions at Dolby Laboratories

In other news, SVP Shriram Revankar sold 7,000 shares of the business's stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $74.92, for a total value of $524,440.00. Following the completion of the transaction, the senior vice president owned 70,435 shares of the company's stock, valued at $5,276,990.20. The trade was a 9.04% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Kevin J. Yeaman sold 25,000 shares of the firm's stock in a transaction dated Tuesday, August 12th. The stock was sold at an average price of $72.31, for a total value of $1,807,750.00. Following the completion of the sale, the chief executive officer directly owned 114,725 shares in the company, valued at approximately $8,295,764.75. The trade was a 17.89% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 99,366 shares of company stock valued at $7,352,963. Insiders own 38.39% of the company's stock.

Analyst Ratings Changes

Several brokerages have issued reports on DLB. Robert W. Baird initiated coverage on shares of Dolby Laboratories in a research note on Friday, September 5th. They issued a "neutral" rating and a $74.00 price objective on the stock. Tigress Financial boosted their price target on shares of Dolby Laboratories from $112.00 to $114.00 and gave the stock a "buy" rating in a research note on Friday, August 15th. Barrington Research restated an "outperform" rating and issued a $100.00 price objective on shares of Dolby Laboratories in a research report on Friday. Rosenblatt Securities reaffirmed a "buy" rating and issued a $95.00 price objective on shares of Dolby Laboratories in a report on Friday, August 1st. Finally, Wall Street Zen raised Dolby Laboratories from a "hold" rating to a "buy" rating in a research note on Saturday, August 30th. Three analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $95.75.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.